awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51431195-1561910E-62D9-4BA0-9F76-A2FBA07CA39C
Q51431195-1561910E-62D9-4BA0-9F76-A2FBA07CA39C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51431195-1561910E-62D9-4BA0-9F76-A2FBA07CA39C
A next-generation anti-IgE monoclonal?
P2860
Q51431195-1561910E-62D9-4BA0-9F76-A2FBA07CA39C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51431195-1561910E-62D9-4BA0-9F76-A2FBA07CA39C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7b2166caafcccc367109bfdfd35d0f9ae36cca0b
P2860
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.